Parcourir l'index des titres "Current and novel antiplatelet therapies for the treatment of cardiovascular diseases"
Voici les éléments 1-1 de 1
-
Current and novel antiplatelet therapies for the treatment of cardiovascular diseases
(MDPI, 2021-12-03)Over the last decades, antiplatelet agents, mainly aspirin and P2Y12 receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. Their pharmacological characteristics, including pharmacokinetic/pharmacodynamics ...